https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
96
 
downloads
10
CITE
How to cite this poster:
Raghunadharao D, Bapsy P and Shan J A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies. F1000Posters 2011, 2:257 (poster)

A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies

D Raghunadharao1, PP Bapsy, JS Shan
Published 19 Apr 2011
Author Affiliations
  • Metrics
  • 96 Views
  • 10 Downloads
Browse by related subjects
Published 19 Apr 2011

A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies

[version 1; not peer reviewed]

D Raghunadharao1, PP Bapsy, JS Shan
Author Affiliations
1 Nizams Institute of Medical Sciences, India
Presented at
44th American Society of Clinical Oncology (ASCO) Annual Meeting 2008
Abstract
Competing Interests

JS Shan discovered this compound and is an employee of Peregrine Pharmaceuticals.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.